Stoke Therapeutics Inc (NAS:STOK)
$ 13.05 -0.05 (-0.38%) Market Cap: 690.88 Mil Enterprise Value: 409.98 Mil PE Ratio: 0 PB Ratio: 2.81 GF Score: 40/100

Stoke Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 14, 2023 / 09:20PM GMT
Release Date Price: $9.01 (-0.44%)
Rudy Li
SVB Securities - Analyst

All right. Good afternoon, everyone. Welcome back to the next session of the SVB Securities Global Biopharma Conference. My name is Rudy Li. I'm from SVB Securities equity research team. So it's my pleasure today to host a fireside chat with Stoke Therapeutics. Joining us today is Barry Ticho, Chief Medical Officer of the company. So for investors who join us today, feel free to send me questions on webcast or you can email me at [email protected]. And with that, let's get it started. So thanks for joining us, Barry.

Questions & Answers

Rudy Li
SVB Securities - Analyst

So for those who are not familiar with your story, maybe we spend a couple of minutes. Give us a brief introduction of the company, the background, the history, and how do we get there?

Barry Ticho
Stoke Therapeutics, Inc. - Chief Medical Officer

Certainly, thank you, Rudy. Thanks for the invitation. It's a pleasure being able to speak to you and to your guests. Just as a quick background, my name

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot